News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Drug Development
Sanofi-Aventis (France) Study Finds Heart Rhythm Drug Cuts Stroke Risk by 1/3
September 3, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BRIDGEWATER, N.J. - An experimental drug to treat irregular heart rhythm reduced the risk of stroke by one-third, according to data presented at the European Society of Cardiology conference Wednesday.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Sanofi (France)
MORE ON THIS TOPIC
Neuroscience
Takeda Establishes Lead in Narcolepsy Race With Back-to-Back Phase III Wins
July 14, 2025
·
2 min read
·
Tristan Manalac
Depression
After Three Strikes, Relmada Abandons Depression Drug Esmethadone
July 14, 2025
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH ECLIPSEBIO
The mRNA Revolution You Haven’t Heard About: From Cystic Fibrosis to Personalized Cancer Vaccines
July 10, 2025
·
1 min read
·
Lori Ellis
Cancer
AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B
July 10, 2025
·
1 min read
·
Dan Samorodnitsky
